Interferon-alpha–induced changes in tryptophan metabolism
Top Cited Papers
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 54 (9) , 906-914
- https://doi.org/10.1016/s0006-3223(03)00173-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inhibition of Norepinephrine Uptake in Patients With Major Depression Treated With ParoxetineAmerican Journal of Psychiatry, 2002
- Neurobehavioral Effects of Interferon-|[alpha]| in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom DimensionsPublished by Springer Nature ,2002
- The role of serotonin in human mood and social interactionPharmacology Biochemistry and Behavior, 2002
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Immune reaction links disease progression in cancer patients with depressionMedical Hypotheses, 2000
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999
- Treatment of Neurotoxic Side Effects of Interferon-α with NaltrexoneCancer Investigation, 1995
- Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infectionImmunology Letters, 1991
- The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disordersJournal of Affective Disorders, 1988
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960